The uptake of an innovative approach to reduce HCV transmission among MSM:
the NoMoreC project
By: Tamara Prinsenberg
International Viral Hepatitis Elimination Meeting Amsterdam 22-23 November 2019
Disclosures
Tamara Prinsenberg:
I have nothing to disclose
MC Free receives funding from:
AbbVie, Gilead Sciences, Janssen, Merck Sharp & Dohme, and Roche
Co-created with the community
Aim: to reduce HCV incidence among MSM in Amsterdam
• Increase HCV awarenesss• Promote willingness to test• Promote risk reduction behaviour
NoMoreC website traffic
Feb 2018 - Nov 2019
Nr of sessions 48,313
Nr of users 30,468
Average nr of pages viewed/ session 4
Bounce rate 11%
Returning visitor 37%
HCV-RNA home-based testing service
• Personalised test advice
• Order test online
• Home sampled DBS
• Result online
• Anonymous
• Linkage to care
Uptake & satisfaction of testing service
Orderedtest
Performed test
Positiveresult
Online evaluationResponse rate 54%
Reasons for ordering test To know my HCV-status (46%)
Concerns about being infected (29%)
Anonymous (29%)
Satisfied with C-test service 96%
Uptake & use of the Toolbox
• Toolboxes ordered online: 66
• Toolboxes distributed in Amsterdam: 217• HIV treatment centers• STI clinic• Fetish shops
Online evaluationResponse rate 26 %
Reasons for ordering Toolbox To reduce risk of getting infected (67%)
To use during sex party (51%)
Used products from the box 87%
Clarity of instructions 93% clear or very clear
Conclusions
• Using a co-creational approach has resulted in a contextually appropriate intervention
• NoMoreC:
• Received postively by MSM community
• Intervention has reached target population
• The test service has successfully diagnosed HCV cases
Acknowledgements
• Gilead Sciences Europe
• Gilead Sciences Netherlands
• Janssen-Cilag
• Abbvie
• Merck Sharpe & Dohme
• Roche Diagnostics Netherlands
• Co-creation group
• Community advisory board
• Scientific advisory board
• NoMoreC Boy Scouts
Many thanks to the funders and supporters of the MC Free consortium andNoMoreC Project